Paige is a computational pathology platform designed to help pathologists, care teams, and researchers make more informed treatment decisions that optimize outcomes. The company’s platform utilizes AI-based technologies that analyze millions of digital pathology images linked to key clinical data modalities of genomic and clinical/EMR data. As of 2020, Paige was the first company to receive both FDA clearance and FDA breakthrough designation for digital pathology products.
Paige was founded in 2018 by Thomas Fuchs and David Klimstra and is based on their research performed at the Memorial Sloan Kettering Cancer Center (MSK).